Mankind Pharma on Wednesday said it has launched a generic version of diabetes medication Empagliflozin in the country.      The company has launched Empagliflozin tablets under brand names Empaglyde, ...

Empagliflozin, which in addition to treating type-2 diabetes, also aids weight loss, and reduces cardiovascular and kidney risks, holds significant promise for volume growth as it becomes more ...

The German pharmaceutical company sold it under the brand name Jardiance. Mankind Pharma, India's fourth-largest firm by ...

Mankind Pharma has launched its affordable generic version empagliflozin in India for diabetes following its patent expiration. The launch follows patent expiration of empagliflozin sold by German ...

India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 crore anti-diabetic drug market in India is growing at 9 per cent or so.

Rajeev Juneja, Vice-Chairman and Managing Director, Mankind Pharma (Image Credits: FE.com) Boehringer Ingelheim’s blockbuster diabetes Drug Empagliflozin is now off-patent in India. On Wednesday ...

Several domestic drug makers, including Mankind Pharma, have launched the diabetes drug Empagliflozin at significantly reduced prices following the expiration of Boehringer Ingelheims patent. Mankind ...

Homegrown pharmaceutical companies launching significantly cheaper generic versions of empagliflozin—a widely prescribed ...

The price of blockbuster diabetes drug empagliflozin has crashed as much as 90%, as several domestic drugmakers have announced the launch generic versions on Wednesday. Mankind Pharma, Alkem ...